JP2017515892A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017515892A5 JP2017515892A5 JP2017507675A JP2017507675A JP2017515892A5 JP 2017515892 A5 JP2017515892 A5 JP 2017515892A5 JP 2017507675 A JP2017507675 A JP 2017507675A JP 2017507675 A JP2017507675 A JP 2017507675A JP 2017515892 A5 JP2017515892 A5 JP 2017515892A5
- Authority
- JP
- Japan
- Prior art keywords
- solution according
- component
- solution
- hydrogen carbonate
- sodium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461984098P | 2014-04-25 | 2014-04-25 | |
| US61/984,098 | 2014-04-25 | ||
| PCT/US2015/017994 WO2015163978A1 (en) | 2014-04-25 | 2015-02-27 | A stable montelukast solution |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017515892A JP2017515892A (ja) | 2017-06-15 |
| JP2017515892A5 true JP2017515892A5 (https=) | 2018-04-05 |
| JP6488003B2 JP6488003B2 (ja) | 2019-03-20 |
Family
ID=54332972
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017507675A Expired - Fee Related JP6488003B2 (ja) | 2014-04-25 | 2015-02-27 | 安定なモンテルカスト溶液 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US9717684B2 (https=) |
| EP (1) | EP3134076A4 (https=) |
| JP (1) | JP6488003B2 (https=) |
| CN (1) | CN106456535B (https=) |
| WO (1) | WO2015163978A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017038732A1 (ja) * | 2015-08-31 | 2017-03-09 | 大蔵製薬株式会社 | モンテルカストの含水医薬製剤 |
| CN108201525A (zh) * | 2017-12-14 | 2018-06-26 | 重庆西南医院 | 一种促进孟鲁司特钠经鼻吸收促进剂及其使用方法 |
| JP7049610B2 (ja) * | 2018-05-21 | 2022-04-07 | 高田製薬株式会社 | レボセチリジン固形製剤 |
| CN108888602B (zh) * | 2018-08-16 | 2021-04-06 | 海南锦瑞制药有限公司 | 一种孟鲁司特钠制剂及其制备方法 |
| EP3846792A4 (en) | 2018-09-06 | 2022-10-12 | Innopharmascreen Inc. | METHODS AND COMPOSITIONS FOR TREATING ASTHMA OR PARKINSON'S DISEASE |
| WO2022103639A1 (en) | 2020-11-16 | 2022-05-19 | Orcosa Inc. | Methods of treating autoimmune or inflammatory conditions with cannabidiol or its derivatives/analogs |
| US11672761B2 (en) | 2020-11-16 | 2023-06-13 | Orcosa Inc. | Rapidly infusing platform and compositions for therapeutic treatment in humans |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7553853B2 (en) | 2003-10-10 | 2009-06-30 | Synthon Bv | Solid-state montelukast |
| WO2005074893A1 (en) | 2004-02-03 | 2005-08-18 | Chemagis Ltd. | Stable amorphous forms of montelukast sodium |
| WO2005089761A1 (en) | 2004-03-17 | 2005-09-29 | Pfizer Limited | Combination for treating inflammatory diseases |
| TWI314454B (en) * | 2005-01-04 | 2009-09-11 | Ct Lab Inc | An oral liquid pharmaceutical composition of leukotriene antagonists |
| EP1904448B1 (en) * | 2005-07-05 | 2011-02-02 | Teva Pharmaceutical Industries, Ltd. | Purification of montelukast |
| WO2007012075A2 (en) * | 2005-07-20 | 2007-01-25 | Dr. Reddy's Laboratories Ltd. | Preparation of montelukast |
| CA2632954A1 (en) | 2005-12-23 | 2007-06-28 | Glade Organics Private Limited | An improved process for the manufacture of montelukast sodium |
| CA2635841A1 (en) | 2006-02-09 | 2007-08-16 | Teva Pharmaceutical Industries Ltd. | Stable pharmaceutical formulations of montelukast sodium |
| IL181607A0 (en) | 2006-02-27 | 2007-07-04 | Chemagis Ltd | Novel process for preparing montelukast and salts thereof |
| WO2007126865A2 (en) * | 2006-03-30 | 2007-11-08 | Patrin Pharma | Leukotriene antagonists via nasal drug delivery |
| SI22382A (sl) | 2006-10-26 | 2008-04-30 | Krka, Tovarna Zdravil, D.D., Novo Mesto | Nov postopek za pripravo montelukasta |
| WO2008058118A2 (en) | 2006-11-06 | 2008-05-15 | Dr. Reddy's Labortories, Ltd. | Preparation of montelukast and its salts |
| WO2009117381A2 (en) * | 2008-03-17 | 2009-09-24 | Dr. Reddy's Laboratories Ltd. | Preparation of montelukast and its salts |
| WO2010107404A1 (en) * | 2009-03-16 | 2010-09-23 | Mahmut Bilgic | Stable pharmaceutical combinations |
| JO3112B1 (ar) * | 2010-03-29 | 2017-09-20 | Ferring Bv | تركيبة دوائية سريعة التحلل |
| TR201009398A2 (tr) | 2010-11-11 | 2012-05-21 | Bi̇lgi̇ç Mahmut | Fiziksel özellikleri geliştirilmiş tablet formülasyonları |
| EP2640355A1 (en) * | 2010-11-16 | 2013-09-25 | Lupin Limited | Stable oral pharmaceutical compositions of montelukast |
| RU2633640C2 (ru) | 2011-09-16 | 2017-10-16 | Ферринг Б.В. | Быстрорастворимая фармацевтическая композиция |
| KR20130076015A (ko) | 2011-12-28 | 2013-07-08 | 주식회사 삼양바이오팜 | 높은 경도를 갖는 속붕정 및 이의 제조 방법 |
| KR101418404B1 (ko) * | 2012-01-06 | 2014-07-10 | 한미약품 주식회사 | 레보세티리진 또는 이의 약학적으로 허용가능한 염 및 몬테루카스트 또는 이의 약학적으로 허용가능한 염을 함유하는 안정한 경구투여용 약학 제제 |
| CN103239450B (zh) * | 2012-02-07 | 2014-11-26 | 齐鲁制药有限公司 | 一种能快速溶出、稳定的孟鲁司特钠口服固体制剂及其制备方法 |
-
2015
- 2015-02-27 WO PCT/US2015/017994 patent/WO2015163978A1/en not_active Ceased
- 2015-02-27 EP EP15783284.1A patent/EP3134076A4/en not_active Withdrawn
- 2015-02-27 CN CN201580022167.0A patent/CN106456535B/zh not_active Expired - Fee Related
- 2015-02-27 US US14/633,585 patent/US9717684B2/en active Active
- 2015-02-27 JP JP2017507675A patent/JP6488003B2/ja not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017515892A5 (https=) | ||
| IN2014DN09973A (https=) | ||
| CN110248926A (zh) | Lsd1抑制剂及其制备方法和应用 | |
| JP2014515039A5 (https=) | ||
| JP2016540701A5 (https=) | ||
| WO2013085810A3 (en) | Co-attrited stabilizer composition | |
| JP2016539873A5 (https=) | ||
| UA96342C2 (en) | Microspheres having core/shell structure | |
| JP2018184433A5 (https=) | ||
| MX2007009936A (es) | Hidroxietilcelulosa en bloques, derivados de la misma, proceso de fabricacion, y usos de los mismos. | |
| NO20084292L (no) | Formulering for legemiddellevering til kolon | |
| NO20091988L (no) | Naturlig ekvivalent av kjemisk modifisert stivelse | |
| WO2017070616A3 (en) | Sexually transmitted disease vaccines | |
| WO2015019198A3 (en) | High potency pancreatin pharmaceutical compositions | |
| NZ599365A (en) | Potato products with enhanced resistant starch content and moderated glycemic response and methods thereof | |
| WO2015051885A3 (de) | Verfahren zum herstellen von halobutyl-kautschuk | |
| Samy et al. | DAMPs and influenza virus infection in ageing | |
| JP2018529626A5 (https=) | ||
| EP4102986A4 (en) | EXPANDED DRY PRODUCT FOR CALORIC RESTRICTION AND FOR SATIATION EFFECT, USES AND METHODS FOR THE PRODUCTION THEREOF | |
| WO2014173941A3 (fr) | Procédé d'obtention d'un gel stable d'acide hyaluronique et d'une forme libre de vitamine c et/ou de l'un de ses sels | |
| RU2013114873A (ru) | Микронизированный крахмал и способы его изготовления | |
| PH12018500604A1 (en) | Modified lysosomal protein and production thereof | |
| CN102924609A (zh) | 一种分步法生产低取代羟丙基纤维素的方法 | |
| MX2017015835A (es) | Gel oftalmico de bimatoprost aplicable en gotas. | |
| WO2008042499A3 (en) | Process for making jelly containing pectin |